Articles by Lou Morris - Pharmaceutical Executive

ADVERTISEMENT

Articles by Lou Morris

Lou Morris


Lou Morris is president of Louis A. Morris & Associates, which specializes in regulatory research and consulting. Morris spent 23 years at FDA and is currently a member of FDAs Drug Safety and Risk Management Advisory Committee. He can be reached at lmorris@optonline.net or (631) 385-1172.

Articles
Backpage: Warning Letter
March 1, 2006

This letter concerns the FDA press release dated January 18, 2006, entitled "FDA Announces New Prescription Drug Information Format to Improve Patient Safety." The information contained is considered false and misleading, and lacking in fair balance.

Backpage: Nailing Down DTC Promotion
January 1, 2006

Arguments over DTC have become more sophisticated, and there is much more middle ground.

The Risk Management Mandate
May 1, 2004

Last year, FDA released a series of concept papers that summarized the agency's plans for risk management. One described a new mandate for the pharmaceutical industry: to develop a risk management plan (RMP) for each drug, to be submitted to FDA at the time of the new drug application. The concept papers still need to be finalized and converted into a guidance (a document that explains how companies may comply with FDA regulations), but the mandate is likely to go into effect this year.

ADVERTISEMENT

Click here